Clin2
NCT06723366Worth exploringNot yet recruiting

Angong Niuhuang for brain injury after heart surgery

Cardio-pulmonary BypassCardiovascular SurgeryCerebral ProtectionBrain Injury

Part of Brain & nervous system, Injuries & trauma clinical trials.

This trial tests whether a traditional Chinese herbal medicine called Angong Niuhuang can help protect the brain and reduce inflammation after a stroke that happens during or after heart surgery. If you have had heart surgery and then a moderate stroke within the last 36 hours, this study may be for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have had heart or blood vessel surgery.
  • You have recently had a stroke (within the last 36 hours) that affects one side of the brain.
  • Your stroke symptoms are moderate to severe (doctors use a stroke scale score of 10–20).
  • You have not taken the herbal medicine Angong Niuhuang in the past month.
  • A traditional Chinese medicine doctor agrees you are suitable for this treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07200921Not yet recruiting· Phase 2
Testing naoxuekang pills for bleeding stroke

This trial tests whether a Chinese herbal pill called naoxuekang can help people recover from a bleeding stroke caused by high blood pressure. It is for people who have had a small to moderate bleed within the last week and are in stable condition.

Beijing, Beijing Municipality
NCT07445581Not yet recruiting
Tanhuo Decoction for seniors with heart and brain artery issues

This trial tests a traditional Chinese herbal formula, Tanhuo Decoction, for elderly patients who recently had a heart attack (acute coronary syndrome) and also have brain artery narrowing or a history of stroke. It aims to see if the medicine helps improve recovery and reduce future risks.

Beijing, Beijing Municipality
NCT07250035Recruiting· Phase 3
Chinese herb trial for brain bleed linked to amyloid angiopathy

This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.

Beijing
NCT06845254Not yet recruiting· Phase 3
Study of Xuesaitong Soft Capsules after heart stent placement

This trial tests whether Xuesaitong Soft Capsules can help people who recently had a heart attack or unstable angina and received a stent. It aims to see if adding this medicine improves recovery and reduces future heart problems.

Beijing
NCT06857487Recruiting· Phase 1/Phase 2
Testing an herb formula to prevent early stroke worsening

This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.

Beijing, Beijing Municipality
NCT07074938Recruiting
Traditional Chinese medicine for brain injury recovery

This trial tests whether a traditional Chinese medicine called An Gong Niuhuang Wan can help people recover brain function after a traumatic brain injury and surgery. It may be a good fit if you are moderately affected (GCS 6–12) and your condition is stable enough to start treatment within three days.

Wuhan, Hubei

Hear when a new Cardio-pulmonary Bypass trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.